Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Michael J Fox Foundation Podcasts

show episodes
 
Artwork

1
The Michael J. Fox Foundation Parkinson's Podcast

The Michael J. Fox Foundation for Parkinson’s Research

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations that include the voices of those affected by Parkinson's as well as clinicians.
  continue reading
 
Artwork

1
The Parkinson’s Research Podcast: New Discoveries in Neuroscience

The Michael J. Fox Foundation for Parkinson’s Research

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
In this podcast, The Michael J. Fox Foundation for Parkinson’s Research brings you right to the cutting edge of neuroscience to discuss the latest discoveries in the field of neuroscience, with a focus on Parkinson’s disease (PD). We are working at the forefront of PD research to accelerate scientific breakthroughs by providing funding opportunities, tools and resources to develop new treatments, find cures and improve quality of life for people living with Parkinson’s disease. If you’re a s ...
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
  continue reading
 
Teresa Jackson from Lean On Me Coaching, shares resources and strategies for thriving with Parkinson's. Join her and her guests to learn how to live your best life in spite of living with a chronic illness.Opinion Disclaimer:The views and opinions expressed in Parkinson’s Pathway Pals Tuesdays with Teresa, are those of the guests and do not necessarily reflect the official policy or position of Teresa Jackson and Parkinson’s Pathway Pals Tuesdays with Teresa. Any content provided by our gues ...
  continue reading
 
Artwork
 
This podcast is dedicated to the millions of family caregivers who want wellness tips and self-care solutions, who seek expert advice, and who want news about healthy aging on how to fuel our bodies and brains, and how to bring wellness design into our forever homes.
  continue reading
 
Loading …
show series
 
As Parkinson’s symptoms change over the years, different treatments may be needed to best manage symptoms and side effects. Since last fall, the U.S. Food and Drug Administration has approved five new options for people living with the disease, including two continuous, under-the-skin infusion pumps. Tune into audio from this Third Thursday’s Webin…
  continue reading
 
Today we’re diving into the world of expression systems with Iskandar Dib, of Validogen and we’ll explore the remarkable potential of Pichia pastoris, a methylotrophic yeast that’s revolutionizing pharmaceutical protein production and beyond. From industrial enzymes to biomaterials, food, feed, and diagnostics, Pichia offers a reliable, scalable, a…
  continue reading
 
In today's episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx. HCRx are pioneers in royalty-based financing, with a thirty year track record in biopharma investing. Clarke has led more than 60 royalty acquisitions totaling nearly $4 billion and raised over $8 billion across various vehicles, executing more th…
  continue reading
 
In our 1st episode for October, host and gerontologist, Sherri Snelling, has two great expert interviews to share: 1) Justin Boogaard – Co-Founder and CEO of GoGoGrandparent. We’re celebrating October National Rideshare Month with Justin! You’ll learn how this rideshare company has created a concierge service specifically designed for older adults …
  continue reading
 
When it comes to contraception, most of the innovation in the last century has focused on providing contraceptive alternatives for women. The contraceptive pill was approved by the FDA in 1960, the first IUD approved in 1968, and the female condom in 1993. For men, however, there has been little advancement since the invention of the rubber condom …
  continue reading
 
Stepping back from the workforce is a milestone event in any life, and Parkinson’s disease (PD) adds an emotional and logistical layer. Many people living with the disease think differently about when and how to retire as they balance symptoms, their financial and health needs and their plans and interests. Tune into this episode of The Michael J. …
  continue reading
 
Raising money in the gene therapy space can be tough right now but, for the right company and with the right team, there is still cash to be found. But how do you connect with investors, how do you get your science in front of the right people, and how do you move from ‘I’m interested’ to ‘I’m signing on the dotted line’? This week I talk with Gera…
  continue reading
 
In our second September episode, host and gerontologist, Sherri Snelling, focuses on World Alzheimer’s Month as she talks with Dr. Tina Sadarangani, creator of Enlightened Caregiver in Instagram for dementia caregiving tips and inspiration as well as her innovative new app, CareMobi, for family care coordination. Sherri and Dr. Tina also talk about…
  continue reading
 
Immunology and inflammation are hot topics in biotech and biopharma, and innovations are emerging that can change the game for patients suffering from autoimmune, gastrointestinal, and metabolic disease. For top pharma companies, identifying these innovations early is essential and, for university labs, spinouts and startups, getting their science …
  continue reading
 
While there have been improvements in therapies to treat Parkinson’s symptoms, people living with the disease and their loved ones await a treatment that will slow the progression of Parkinson’s disease (PD) or stop it entirely. These therapies, called disease-modifying therapies, have the potential to change how PD is treated and experienced. Tune…
  continue reading
 
In this September episode, host and gerontologist, Sherri Snelling, talks with Wayne Lehrer, author of the new book, “The Art of Conscious Aging for National Healthy Aging Month. For CAREGIVER WELLNESS NEWS, Sherri dives into the secrets of living longer such as eating the breakfast foods that those who reach age 100 love for National Centenarian D…
  continue reading
 
Partnering conferences are where many deals in the biotech industry get made. With investors and top pharma companies on hand to meet with founders, learn about new science, and put money on the table for promising biotech, it’s little wonder that the biggest partnering events attract hundreds of innovators and thousands of attendees. One of the la…
  continue reading
 
How can you guarantee that top pharma will be interested in investing in your biotech startup? How can you be sure that the target you are focused on will be attractive to industry partners? And can AI help drive this interest and deliver these partnerships? These are questions that this week’s guest, Mati Gill, CEO of AION Labs in Israel, is perfe…
  continue reading
 
A Parkinson’s disease (PD) diagnosis can impact many areas of life, including how you get work done and think about your career. It can lead to questions like: Should I disclose my diagnosis to my employer and colleagues? How do I adapt my work around my symptoms? What legal protections do I have? Tune into this episode of The Michael J. Fox Founda…
  continue reading
 
Lonza is one of the world’s largest contract development and manufacturing organizations (CDMOs), dedicated to serving the healthcare industry. They work alongside a broad range of customers – from emerging biotechs to top global pharmaceutical companies – to transform therapeutic discoveries into life-saving and life-enhancing treatments for their…
  continue reading
 
Our August episode has host and gerontologist, Sherri Snelling, talking with Savenia Falquist of HomeShare Oregon about a roommate finding service for older adults. Looking to support older adults who are living at home and help them with avoiding loneliness while also boosting their financial resilience, this is what we call “Golden Girls 2.0.” Sa…
  continue reading
 
Parkinsons disease impacts some 10 million people worldwide and current approaches to treating the condition almost exclusively focus on addressing symptoms – there is, as of yet, no cure. One Finnish biotech, however, is not focused on alleviating symptoms but on modifying the course of the disease itself. Their hope is to be able to stop and even…
  continue reading
 
Researchers are investigating many options to treat Parkinson’s disease (PD) with stem cells, including reprogramming them to replace lost dopamine-producing neurons and creating supportive brain cells to keep neurons healthy. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss the latest stem cell research a…
  continue reading
 
RNAi has changed the way that rare diseases are treated - is it about to do the same for more common conditions? Alnylam was the very first company to translate RNAi from Nobel Prize winning science into a commercially scalable platform. Founded in 2002, the company today has five different RNAi therapies on the market and a pipeline that continues…
  continue reading
 
How do I tell my children about my Parkinson’s disease (PD) diagnosis? How do I explain a tremor to my grandkids? How can I support my parent with Parkinson’s from a distance? How can my spouse and I communicate around a symptom of apathy? Every year our community submits thousands of questions online and at in-person events. Many are about Parkins…
  continue reading
 
Nearly 1 billion people around the world suffer from mental health disorders, with the global economic cost of those disorders expected to reach $6 trillion by 2030. One of the most common of those mental health disorders is depressive disorder, commonly called depression, with some 280 million people suffering from either mild, moderate or severe …
  continue reading
 
The UK is preparing to change the game for healthcare - but why, how, and what will it cost? Recently the UK government announced plans to sequence the DNA of every baby born in that country. A part of the country’s 10 Year Health Plan, the program aims to identify rare genetic diseases early, prevent harms from delayed treatment and reduce future …
  continue reading
 
Is cultivated meat the future of pet food? And is there a place for cultivated meat on human dinner tables, too? Traditional agricultural methods are slow, require large tracts of land, significant energy and environmental inputs, and – somewhat obviously – the slaughter of hundreds of millions of animals every year. Cultivated meat – that is meat …
  continue reading
 
With supply chain management and optimization, risk management, and the capacity to address global markets efficiently and effectively top of mind for all growing biotechs, I'm excited to be joined by Alison Pritchard, Vice President, Business Development at Cryoport Systems, to learn more about how they support life science innovators worldwide. C…
  continue reading
 
Our July episode has host and gerontologist, Sherri Snelling, talking with Saudia Gajadhar, Chief Happiness Officer at Comfort Keepers about this year’s National Day of Joy survey among older adults and family caregivers and Comfort Keepers’ role in the new PBS documentary, “Caregiving.” In CAREGIVER WELLNESS NEWS, Sherri shares the latest stats to…
  continue reading
 
Technology can offer people living with Parkinson’s disease (PD) much needed support in several areas of life, from apps to keep track of medication timing, wearables to help smooth gait, websites to monitor symptoms and more. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss how tech tools can be incorpora…
  continue reading
 
Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, immunity, circulation, breathing, and the nervous system. The demand for anti-inflammatory treatments is growing quickly and is tipped to top a quarter of a trillion dollars within the decade as cases i…
  continue reading
 
Advances in imaging technology offer researchers a window into how Parkinson’s disease affects the brain, which could reshape how the disease is diagnosed and treated. In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, in its award-winning Parkinson’s Science POV series, David Kumbroch, senior science writer at MJFF, lead a conve…
  continue reading
 
Ros Deegan is an industry leader and the CEO of OMass Therapeutics, an Oxford-based biotechnology company discovering medicines against highly-validated target ecosystems, such as membrane proteins or intracellular complexes. OMass’s MC2 program targeting Congenital Adrenal Hyperplasia, or CAH, is set to enter the clinic this year and in our interv…
  continue reading
 
Having a network of health care professionals, loved ones and community members as part of a care team has shown to improve the quality of life for those living with Parkinson’s disease (PD) and their loved ones. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts discuss how to make the most of your appointments, fi…
  continue reading
 
For our June episode host and gerontologist, Sherri Snelling, talks with the authors of the new “AARP Caregiver Answer Book” – Barry Jacobs and Julia Mayer. They share some of the insights from the book including the difference in caring for a spouse versus an older parent, how and why families need to have the caregiving conversation, how to adopt…
  continue reading
 
The World Health Organization reports that more than 600 million people suffer from lower back pain globally, making it the leading cause of disability worldwide. Chronic lower back pain – where the pain persists for more than 3 months – develops in between 5 and 10% of all lower back pain cases, with life-altering impacts for patients. And that’s …
  continue reading
 
Trauma surgeons in Ukraine operating theaters saved lives and limbs thanks to the innovative lab-grown blood vessels from US biotech, Humacyte. Humacyte is pioneering a platform that enables the investigation, development, and manufacture of bioengineered human tissues and organs that are designed to be universally implantable, off-the-shelf, and r…
  continue reading
 
Much of the attention of the biotech industry has been focused on the city of Boston this week as the annual BIO International Convention hit town. BIO is the world’s largest partnering conference for the biopharma industry and thousands of innovators, out-licensors, venture capitalists, top pharma dealmakers, thought leaders and more than a few po…
  continue reading
 
Life with Parkinson’s disease (PD) is shaped by myriad factors, including sexual orientation and gender identity that shape access to care, lifestyle decisions and more. In this episode of The Michael J. Fox Foundation’s Parkinson’s Podcast, our expert panel shares their personal stories and discusses the ongoing research into the health concerns a…
  continue reading
 
What are the most interesting questions in biotech, and is it even possible to find answers to those questions? Alex Telford is the co-founder of Convoke and a biotech blogger from the San Francisco Bay Area. His blog post, 'Some questions about biotech that I find interesting' provoked conversations online as readers engaged with questions about t…
  continue reading
 
When biotechs start fundraising they regularly turn to the venture capital market seeking investment. The pool of VC money can be large, and part of that pool is corporate venture capital. Backed by firms keen to identify the next big thing in biotechnology, corporate VC money can be an attractive way for biotechs to raise funds privately while ben…
  continue reading
 
Biotechnology has always been a dynamic domain, but the world of finance that provides the fuel for the fire is just as vibrant. Trying to predict where the market for biotech investment is heading is always risky but for experts like Baker McKenzie’s Roel Meers, understanding where the market is moving is where he eats. I spoke to Roel this week t…
  continue reading
 
The beliefs and perceptions that friends, family, employers and even strangers hold about Parkinson’s disease (PD) shape the experience of living with the disease. Facing misperceptions and stigma can cause isolation and worsen symptoms. Tune into audio from this Third Thursdays Webinar to listen to our panel of experts have a candid and compassion…
  continue reading
 
Generative artificial intelligence (GenAI) is already changing how people research, communicate, and interact, but its biggest impacts on biotech are still to come. Cradle is a Dutch-Swiss biotech startup founded in 2021 that has developed a web-based software platform leveraging GenAI to accelerate protein design and optimization, aiding scientist…
  continue reading
 
There are so many ways to get involved with Parkinson’s disease, from community building to advocacy, research participation to fundraising. Taking that first step toward involvement can be daunting, but many people say it’s a critical part of living well with the disease. In this episode of The Michael J. Fox Foundation Parkinson’s Podcast, member…
  continue reading
 
May is a BIG month and we have two great guests for this episode: Harry Margolis, Elder Law Attorney and Linda Kafka, Founder/Principal of Neuro Design Academy. Since May is both National Elder Law Month and Home Modification Month, these two experts are perfect for this episode to share valuable information caregivers do not want to miss! In our C…
  continue reading
 
There are cell therapies, gene therapies, and biologics – and then there is Immusoft. Immusoft sits at the nexus point of some of the most innovative approaches in biopharma, and their Immune System Programming platform is unique in its capacity to address the rare disease, MPS I. This week we talk with Immusoft CEO Sean Ainsworth to learn more abo…
  continue reading
 
Flagship Pioneering doesn't go out to find the next big thing in biotech when investing their billions in fund capital - instead, they take a different route. Flagship Pioneering has founded more than 100 companies in the life sciences worth in total an estimated $75 billion. With a proven model for biotech startup success and a culture designed to…
  continue reading
 
Are TCR-NK treatments the next big thing in cell therapies for cancer patients? As biotechs and pharma companies continue to innovate to address patient needs in oncology, T-cell receptor therapies, or TCR-Ts, are attracting significant interest and investment. There are already some promising results for TCR-Ts tackling solid tumors – but one Norw…
  continue reading
 
AI is driving innovation across industries, including biotech, but where is its influence felt most and what opportunities for future impact are emerging? David del Bourgo is the co-founder and CEO of WhiteLab Genomics, an innovative biotech that is leveraging the power of AI to accelerate drug discovery and development from its Paris, Boston, and …
  continue reading
 
Life with Parkinson’s comes with a vast range of emotions, wherever you are in your disease journey. Shock, grief, optimism, fear, denial, hope, humor and more can all be a part of the emotional landscape for people living with the disease and their loved ones. Tune into audio from this special edition Third Thursdays Webinar to listen to our panel…
  continue reading
 
From llamas and camels to humans worldwide. Nanobodies are enjoying success in the clinic and experts are hailing these camelid-derived biologics as one of the next big things in immunotherapy. Kristian Reich is co-founder and CSO of MoonLake Immunotherapeutics. After a long and distinguished career as a clinician and researcher, Kristian helped to…
  continue reading
 
We are kicking off April with what is top of mind for everyone – how AI (artificial intelligence) is affecting and changing aging and caregiving. We have two experts in this area: Lawrence Kosick, Co-Founder of Get Set Up and Dor Skuler, Founder and CEO of Intuition Robotics, makers of ElliQ. They talk about how they are using AI to help both older…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play